In Focus

Current topic

---

08/13/2010
Bayer Schering Pharma supports special training for doctors in Tibet
It’s hard to visit a doctor in rural Tibet. With better local health care, there’s less need for costly trips to distant medical centres: 40 Doctors from across Tibet are preparing to go back to their rugged rural clinics armed with new skills and techniques gained through training sponsored in part by Bayer Schering Pharma. more

Further information and background details

---

06/24/2010
IMI – Innovative Medicines Initiative: Project Eu2P
Pharmaceutical companies and academic institutions have come together in the IMI and are jointly developing both a European master's degree course and a three-year doctorate program in this important field. This is the Eu2P project (European Program in Pharmacovigilance and Pharmacoepidemiology). more

---

05/26/2010
Bayer Schering Pharma launches drawing competition for young people impacted by MS
On World MS day, May 26th, Bayer Schering Pharma has launched of the Dreams for My Family contest for young artists impacted by MS. The global art competition allows children whose lives are affected by multiple sclerosis (MS) to express their future dreams for their families. more

---

04/30/2010
IMI – Innovative Medicines Initiative
The SAFESCIMET project: a new master's degree course to train experts in drug safety more

---

03/23/2010
On March 24 is World Tuberculosis Day
The fight against tuberculosis (TB), which tops the global statistics of fatal infectious diseases, is one of the greatest medical challenges of all. Someone dies of tuberculosis about every 20 seconds; this corresponds to almost 5,000 people every day. more

---

02/22/2010
IMI – Innovative Medicines Initiative
EMTRAIN: European platform for new educational and training programs in pharmaceutical medicine more

---

12/15/2009
IMI – Innovative Medicines Initiative
SAFE-T Project: researchers search for biomarkers to improve the early detection of drug-induced organ damage more

---

12/03/2009
Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
German Federal President Horst Köhler praises outstanding innovation achievement / Development of the novel oral anticoagulant rivaroxaban commended more

---

11/30/2009
Sex education protects people against AIDS
When you talk about AIDS, you have to talk about sex. We know how important sex education is from our many years of experience in the field of hormonal contraception. Our attitude toward sex education is not limited to the issue of contraception, however, but also encompasses a responsible way of dealing with oneself and one’s body in general. more

---

10/19/2009
First World Health Summit took place in Berlin
The first World Health Summit took place from October 14 – 18, 2009 in Berlin under the heading “The Evolution of Medicine”. International leaders from politics, industry and the scientific community met in Berlin to discuss urgent aspects of global health. The World Health Summit was also the first event in a year of celebrations to mark the 300th anniversary of the Charité hospital in 2010. more

---

09/30/2009
Bayer Schering Pharma supports healthcare partnerships in developing countries
On Monday, September 21, 2009, in Berlin, about 40 representatives of nongovernmental organizations (NGOs), pharmaceutical companies, research institutions and development-aid initiatives discussed partnership initiatives aiming to improve healthcare in developing countries. The conference was jointly organized by Kreditanstalt für Wiederaufbau (KfW) and Bayer Schering Pharma AG. more

---

09/14/2009
Innovative Medicines Initiative: Putting Europe at the Forefront of Biopharmaceutical Innovation
Today, the Innovative Medicines Initiative (IMI), the public-private partnership between the European Commission and the European pharmaceutical industry, represented by EFPIA, made its first major announcement of the success of the collaboration. IMI announced the topics of research of its second call for proposals and introduced its newly-appointed Executive Director, Michel Goldman. more

---

09/10/2009
World Heart Day 2009 – Bayer teams up with World Heart Federation , 27th September 2009
Cardiovascular disease (CVD) remains the No. 1 cause of death worldwide — killing one person every two seconds. An estimated 17.5 million people died from CVD in 2005, and this number is expected to rise to 20 million by 2015. more

---

07/11/2009
Bayer Schering Pharma: Taking Social Responsibility in Family Planning
In 1994, the United Nations International Conference on Population and Development in Cairo reaffirmed that it is the basic human right of each individual to determine freely and responsibly the number and timing of their children. 15 years later, however, modern contraceptives remain out of reach for millions of people. more

---

07/09/2009
EFPIA press release on final European Commission report into the pharmaceutical sector
EFPIA, the association of the pharmaceutical industry in Europe, has decided to respond to the publication of the final European Commission report into the pharmaceutical sector on July 8, 2009 by issuing a press release. Commented Arthur J. Higgins, President of the EFPIA and CEO of HealthCare AG, “We have stated consistently that complex and divergent regulatory barriers are the primary cause of market entry delay for both generic and innovative medicines. We are pleased that the final report recognises this reality.” more

---

06/26/2009
Bayer Schering Pharma committed to efficient and safe drug development
The European pharmaceutical manufacturers’ association EFPIA and the European Commission launched the Innovative Medicines Initiative (IMI) in February 2008 with the aim of making the drug-development process more efficient and safer. more

---

05/28/2009
New hope in the fight against African sleeping sickness

A combination therapy using a drug from Bayer Schering Pharma has been added to the WHO's List of Essential Drugs.
According to the WHO, African sleeping sickness, also known as African trypanosomiasis, threatens almost 60 million people in sub-Saharan Africa alone.

more

---

05/14/2009
Annual Meeting 2009 of the research-based pharmaceutical industry in Europe (EFPIA) in Seville, 13-15 May
EFPIA, the voice of the pharmaceutical industry, called on governments and policymakers throughout Europe to use the financial crises as a real opportunity to make healthcare systems fit for the 21st century, and not as yet another excuse for cutting health and pharmaceutical expenditure. more

---

04/27/2009
Girls’ Day And Boys’ Day 2009: One Day Like A Real Scientist
On 23. April, Girls’ Day took place at Bayer Schering Pharma in Berlin, Germany. This national day of action was especially founded to familiarize young girls with jobs from the domains of natural sciences and technology. It is designed to inspire them to get involved in topics that have until now been mostly dominated by men. more

---

12/12/2008
Bayers Perspective on Innovation 2008
12th December 2008 - New technologies and products at the Perspective on Innovation 2008
At this year´s press conference on "Bayer´s Perspective on Innovation 2008", innovation champions of the Bayer group were in the focus. Werner Wenning (Chairman of the Board of Management of Bayer AG) and Dr. Wolfgang Plischke (member of the Board of Management of Bayer AG, responsible for innovation, technology and environment) presented the work in research and development at Bayer HealthCare, Bayer Crop Science and Bayer Material Science. more

---

12/10/2008
Improving patient safety and information to patients in Europe
On Dec 10, 2008 the European Commission adopted a series of measures on pharmaceutical regulation. The long awaited "Pharmaceutical Package" comprises three legislative proposals and a renewed vision of the Commission for the pharmaceutical sector". more

---

12/10/2008
Newly adopted pharmaceutical package recognises importance of pharmaceutical industry – need to ensure patient safety is key
On Dec 10, 2008 The European Commission published a package of proposals on pharmaceutical regulation.
EFPIA, the voice of the research-based pharmaceutical industry in Europe welcomes the release of the long-awaited European Commission’s ‘Pharmaceutical package’. However EFPIA urges the institutions not lose focus on the core issue of patient safety. more